Zoetis Inc. (ZTS)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$116.49
-1.17%
Mkt Cap $51.80B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $2.36B | $2.39B | +1.14% | $1.40 | $1.48 | +5.71% | — | — |
| Q4 2025 Nov 4, 2025 | $2.41B | $2.40B | -0.41% | $1.62 | $1.70 | +4.94% | — | — |
| Q3 2025 Aug 5, 2025 | $2.41B | $2.46B | +2.10% | $1.62 | $1.76 | +8.64% | — | — |
| Q2 2025 May 6, 2025 | $2.19B | $2.22B | +1.37% | $1.41 | $1.48 | +4.96% | — | — |
| Q1 2025 Feb 13, 2025 | $2.30B | $2.32B | +0.86% | $1.37 | $1.40 | +2.19% | — | — |
| Q4 2024 Nov 4, 2024 | $2.29B | $2.39B | +4.34% | $1.46 | $1.58 | +8.22% | — | — |
| Q3 2024 Aug 6, 2024 | $2.31B | $2.36B | +2.10% | $1.49 | $1.56 | +4.70% | — | — |
| Q2 2024 May 2, 2024 | $2.15B | $2.19B | +1.70% | $1.34 | $1.38 | +2.99% | — | — |
| Q1 2024 Feb 13, 2024 | $2.19B | $2.21B | +1.13% | $1.32 | $1.24 | -6.06% | — | — |
| Q4 2023 Nov 2, 2023 | $2.18B | $2.15B | -1.35% | $1.36 | $1.36 | +0.00% | — | — |
| Q3 2023 Aug 8, 2023 | $2.17B | $2.18B | +0.68% | $1.32 | $1.41 | +6.82% | — | — |
| Q2 2023 May 4, 2023 | $2.01B | $2.00B | -0.59% | $1.26 | $1.31 | +3.97% | — | — |
| Q1 2023 Feb 14, 2023 | $2.00B | $2.04B | +1.85% | $1.05 | $1.15 | +9.52% | — | — |
| Q4 2022 Nov 3, 2022 | $2.08B | $2.00B | -3.91% | $1.24 | $1.21 | -2.42% | — | — |
| Q3 2022 Aug 4, 2022 | $2.03B | $2.05B | +1.30% | $1.22 | $1.20 | -1.64% | — | — |
| Q2 2022 May 5, 2022 | $1.98B | $1.99B | +0.43% | $1.23 | $1.32 | +7.32% | — | — |
| Q1 2022 Feb 15, 2022 | $1.93B | $1.97B | +1.79% | $0.96 | $1.00 | +4.17% | — | — |
| Q4 2021 Nov 4, 2021 | $1.93B | $1.99B | +2.99% | $1.10 | $1.25 | +13.64% | — | — |
| Q3 2021 Aug 5, 2021 | $1.82B | $1.95B | +6.79% | $1.08 | $1.19 | +10.19% | — | — |
| Q2 2021 May 6, 2021 | $1.73B | $1.87B | +8.33% | $1.03 | $1.26 | +22.33% | — | — |